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Abstract  
BACKGROUND: Elderly population (≥ 65) are more prone to develop acute kidney injury (AKI) compared to 
younger, also elderly with AKI have an increased requirement for dialysis treatment and an elevated risk of short-
term and long-term mortality. 
AIM: The objectives of this study were to examine the effect of treatment of short-term outcomes and mortality in 
elderly patients with AKI. 
MATERIAL AND METHODS: Seventy elderly AKI patients, that filled one of the criteria of AKI definition and had 
hospitalization over 24 hours, were enrolled in the study. 
RESULTS: The median age of patients was 74.28 ± 6.64, with mean CCI (Charlson Comorbidity Index) score of 
6.94 ± 1.94. The majority of patients (70%) were classified at stage 3 of AKIN, 20% of patients were classified at 
stage 2 and 10% at stage 1. In the groups of patients with death outcome, the chronic cardiomyopathy was more 
frequently present (p = 0.034). Regarding treatment, 58.6% of the AKI patients underwent hemodialysis while 
41.4% received conservative treatment. Mortality rate was 52.8%, out of which 28.6% was in-hospital mortality, 
while in 24.3% of patients death occurred in the follow-up period of 90 days. 
CONCLUSION: In our study, short- term survival is not related to different treatment options. Applied treatment in 
elderly patients with AKI should be assessed by measuring the long term outcome. 
 
 
 
 
 
 
Introduction 
 
Acute kidney injury (AKI), previously termed 
as acute renal failure (ARF), is a common acute 
syndrome characterized by an abrupt or rapid decline 
in renal filtration function [1]. The elderly (≥ 65) are 
particularly vulnerable to renal insults which are 
explained with age related structural and functional 
changes that lead to decreased glomerular filtration 
rate, vascular dysautonomia, and alter diminished 
renal reserve [2]. Increased longterm life expectancy 
is commonly is accompanied with chronic diseases 
such as hypertension, diabetes mellitus, and 
cardiovascular diseases. Also, elderly patients are 
exposed to multiple medications with related toxicity 
and invasive procedures. These risk factors together 
make elderly susceptible to AKI. The incidence of AKI 
in the elderly population is higher than in younger, and 
age as a predictive factor of outcomes and mortality is 
reported by multiple studies [3-5].  
An increased requirement has also been 
reported for dialysis treatment in the elderly with AKI, 
and the incidence is up to 10 times higher compared 
to patients under 65 years of age [6-8]. Older patients 
with AKI have an elevated risk of both short-term and 
long-term mortality [9, 10] and survivors are often left 
with multiple chronic conditions which make prognosis 
significantly poor at the time after hospital discharge. 
Elderly patients with AKI have significantly higher 
chance of non-recovery of renal function [5] and 3-20 
fold higher risk of subsequent chronic kidney disease 
(CKD) [11] that eventually progresses to end stage 
renal disease (ESRD), particularly in the case of AKI 
and prior CKD [12]. The objectives of this study were 
to examine the effect of treatment of short-term 
outcomes and mortality in elderly patients with AKI. 
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Material and Methods 
  
The prospective observational study has been 
conducted at the University clinic of nephrology 
Skopje. In the study, seventy patients that were 
treated at the Clinic of nephrology Skopje over the 
period of 8 months were enrolled in the study. The 
study protocol was approved by the ethic commission 
of Medical Faculty in Skopje, and written consents 
were obtained from the patients enrolled in the study 
or by a family member. 
Inclusive criteria were: Age ≥65, filling out one 
of the criteria of the definition of AKI according to 
Kidney Disease Improving Global Outcome (KDIGO) 
and hospitalization above 24 hours. Patients with 
chronic kidney disease (CKD) on maintenance 
dialysis or peritoneal dialysis and renal transplantation 
were excluded.  
 Laboratory parameters, urea, serum 
creatinine, sodium, potassium, calcium, phosphate, 
serum albumin, C-reactive protein (CRP) levels were 
measured at admission for all subjects. Clinical data 
include patient’s age, gender, admission and 
discharge data, causes of AKI and applied treatment. 
Data about co-existing comorbidities was taken from 
patient’s medical records or were diagnosed during 
the hospitalization. The burden of comorbidities was 
estimated by Charlson comorbidity index (CCI).This 
index incorporates age and 19 different medical 
conditions, each weight from 1-6 according to its 
impact on mortality [13]. The age is adjusted by 
calculating each decade after 40 years of age at one 
point. The total sum of all the weights results in a 
single comorbidity score for a patient.The standard 
algorithm proposed by Quan et al. was used to define 
the Charlson comorbidity index (CCI) score [14]. 
  Patients were divided into groups of survivors 
and nonsurvivors based on their survival status at 90 
days. Depending on the treatment patients were 
divided into groups of patients treated with 
hemodialysis and groups of patients treated 
conservatively. The indications for the initiation of 
hemodialysis were volume overload inadequately 
controlled with diuretics, refractory hyperkalaemia to 
conservative measures, the presence of insufficient 
urinary output, uraemic signs or symptoms and clinical 
severity of illness of patients. The less severe patients 
with preserved diuresis were treated conservatively. 
Pre-existing chronic kidney disease (CKD) was 
estimated by the value of serum creatinine (sCr) over 
the last three months before the current episode of 
acute injury as it is recommended by KDIGO. When 
the value sCr was not available, the consensus 
committee recommended the use of the back-
calculation [15] with the Modification of Diet in Renal 
Disease (MDRD) to estimate patients GFR, assuming 
all patients had a normal GFR of 75 ml/min, or the 
lowest value of sCr during hospitalization or 
respectively at discharge. We defined short-term 
patient’s mortality as a death during the hospital stay 
or death within follow up 90 days of diagnosis of AKI. 
 
Definition and classification of AKI 
 AKI was defined as an increase in SCr by 
26.5ulmol/l within 48 hours or a 50% increase in SCr 
from the baseline within seven days according to the 
KDIGO criteria (16). By KDIGO criteria, AKI is 
classified at three stages by severity determined using 
the peak sCr level after AKI onset.  
Table 1: Characteristics of AKI population 
Characteristics  
Age ( years) 74.28 ± 6.64 (65-91) 
Gender male/female)  33 (47%) /37 (53%) 
Length of stay ( LOS) days 9.13 ± 5.69 (1-30) 
CCI score 6.94 ± 1.94 
sCr (admission) 667.81 ± 286.72 (202-1623) 
sCr (discharge) 238.57 ± 175.06 (58-844) 
GFR (ml/min) 38.33 ± 24.96 (7-108) 
Pre- existing CKD 31 (44.3 %) 
CHF 33 (47%) 
Diabetes mellitus 30 (42.8 %) 
Urine output (ml) 989.38 ± 746.25 
 Anuria 6 (8.6%) 
 Oliguria 14 (20%) 
 Diuresis  500ml 50 (71.4%) 
AKIN  
 Stage 1  7 (10%) 
 Stage 2 14 (20%) 
 Stage 3 49 (70%) 
Treatment  
(HD/Conservative) 
 
41 (58.6%) / 29 (41.4%) 
Mortality  
Intra hospital 20 (28.6%) 
During 90 days follow-up 17 (24.3%) 
Total 37 (52.8%) 
Survived ≥ 90 days 33 (47.1%) 
Abbreviations: CCI, Charlson comorbidity index; SCr, serum creatinine; GFR, glomerular 
filtration rate; AKIN, CHF, chronic heart failure; Acute Kidney Injury Network; LOS Length 
of hospital stay. Data are presented as means and standard deviation. 
 
Statistical analysis  
 The results are presented with descriptive 
statistics expressed as the mean ± standard deviation. 
For comparison of the two groups, Student’s﮲ test was 
used. 
2 
test or Fisher’﮲s test was used to compare the 
two groups with categorical (nominal) variables. 
Cumulative proportion surviving Kaplan Meier 
(significance test, log-rank) was used for statistical 
processing of the data where mortality was the 
outcome. P values less than 0.05 were considered 
statistically significant. 
 
 
Results 
  
Seventy patients (53% female) who met 
inclusion criteria were included in the study, with 
average age 74.28 ± 6.64 years and with mean CCI 
score of 6.94 ± 1.94. The most common comorbid 
condition was chronic heart failure with 47% of 
patients and diabetes mellitus with 42.8%. Pre-
existing chronic kidney diseases was present in 
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44.3%. The majority of the patients (70%) were 
classified as stage 3 of AKIN, 20% of patients were 
classified as stage 2 and 10% as stage 1. Regarding 
treatment, 58.6% of the AKI patients underwent 
hemodialysis while 41.4% received conservative 
treatment. Mortality rate was 52.8%, out of which 
28.6% was in-hospital mortality, while in 24.3% of 
patients death occurred in follow up 90 days. Baseline 
and demographic characteristics of the enrolled 
patients are presented in Table 1.  
 The most frequent causes of AKI in our 
population were prerenal causes (36 patients, 51.4%, 
volume depletion, hypotension), postrenal (14 
patients, 2%, obstruction, malignancy), cardiovascular 
event (11 patients, 15.7%, cardiorenal syndrome- 
CRS), sepsis with 11.4% and renal cause was less 
frequent, with 1.4%. 
 
Figure 1: Causes of AKI 
 
 Comparison of clinical and laboratory 
parameters between survivor and no- survivor AKI 
patients is shown in Table 2.  
Table 2: Comparison of clinical and laboratory parameters 
between survivor and no- survivor AKI patients 
Characteristics  
Survivor 
N = 33 
Non survivor 
N = 37 
p 
Age ( years)  73.76 ± 6.96 74.76 ± 6.39 n.s 
CCI scor  6.55 ± 2.02 7.9 ± 1.83 n.s 
DM vs non DM  12 (17.14%) /21 (30.0%) 18 (25.7%)/19 (27.14%) n.s 
Preexisting CKD vs without 
CKD  
17 (24.3%)/16 (22.9%) 14 (20%)/23 (32.8%) 
n.s 
HD vs Conservative 
treatment  
19 (27.1%)/14 (20%) 22 (31.3%)/15 (21.4%) 
n.s 
CHF vs non CHF  11 (15.7%)/22 (31.4%) 22 (31.4%)/15 (21.4%) 0.025 
sCr (µmol/l)  684.91 ± 297.04 652.57 ± 280.41 n.s 
BUN (mmol/l)  37.38 ± 18.19 40.19 ± 14.03 n.s 
GFR (ml/min)  37.95 ± 22.08 38.69 ± 27.71 n.s 
Hb (g/l)  109.79 ± 20.69 108.83 ± 20.49 n.s 
Plt (х10
9
/l)  247.42 ± 101.34 223.89 ± 113.36 n.s 
CRP ( mg/L)  96.19 ± 101.01 132.93 ± 97.46 n.s 
Na (mmol/l))  136.67 ± 6.83 135.54 ± 7.54 n.s 
K (mmol/l)  5.23 ± 1.50 5.06 ± 1.23 n.s 
Ca (mmol/l)  2.11 ± 0.20 2.01 ±  0.20 n.s 
Alb (g/l)  33.29 ± 5.84 31.15 ± 6.19 n.s 
Du (ml)  1222.76 ± 779.75 801.39 ± 671.14 0.022 
LOS (days)  11.78 ± 5.87 6.84 ± 4.45 0.000 
Abbreviations: CCI, Charlson comorbidity index; SCr, serum creatinine; BUN, blood urea 
nitrogen; GFR, glomerular filtration rate; Hgb, haemoglobin; Plt, platelets; CRP, C-reactive 
protein; Na, sodium; K, Potassium; Alb, albumin; Du, urine output LOS Length of hospital 
stay. 
 
Deceased AKI patients had a higher 
percentage of chronic heart failure (CMP) (p = 0.025) 
as well as lower diuresis and shorter length of stay 
which is statistically significantly different compared to 
the group of survivors. (p = 0.022). A significant 
association was not registered among the other 
compared clinical and laboratory variables in the two 
groups of patients, survivors and non-survivors. 
  When comparing the three groups of patients 
according to the outcome: survivors (≥ 90 days), the 
group of patients in which death occurred during 
hospitalization and during follow up period up to 90 
days, we found that the age was similar in these three 
groups. The group of survivors had significantly higher 
diuresis compared to the other two groups (p = 0.001). 
Also, they had longer hospital stay (p = 0.000). In the 
groups of patients with death outcome, the chronic 
cardiomyopathy was more frequently present (p = 
0.034). The value of serum Cr at admission was 
significantly higher in the group of patients in which 
death occurred during hospitalization (p = 0.029). 
These statistical differences among the AKI patients 
that were divided according to the outcomes are 
presented in Table 3. 
Table 3: Statistical significant differences among the AKI 
patients according to the outcome 
 
Characteristics 
In-hospital 
mortality 
N=20 
Deceased during the 
follow-up 
N=17 
 
Survivor 
No=33 
 
p 
Age ( years) 73.80 ± 6.53 75.88 ± 6.22 73.75 ± 6.95 n.s 
Diuresis (ml) 497.36 ± 466.98 1141.17 ± 712.44 1222.75 ± 779.75 0.001 
LOS (days) 4.65 ± 3.86 9.41 ± 3.73 11.78 ± 5.87 0.000 
CHF 28.6% 24.3% 47.1% 0.034 
sCr-admission 349.30 ± 226.52 192.02 ± 104.71 217.65 ± 167.09 0.029 
Abbreviations: LOS Length of hospital stay; CHF, chronic heart failure; SCr, serum 
creatinine. 
 
 We plotted Kaplan–Meier survival curves 
stratified by urine output at the time of initiation of 
renal replacement therapy. Fig. 2 shows that a 
decreased urine output was associated with lower 
survival (p = 0.001 by the log-rank test). 
 
Figure 2: Survival curves according to the urine output at the time of 
initiation of renal replacement therapy 
 
 According to treatment patients were divided 
into 2 groups: group of patients treated with 
hemodialysis and group of patients treated 
conservatively. As shown in Table 4, significant 
difference between the hemodialysis vs conservatively 
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treated group of patients was evident in sCr at 
admission (765.24 μmol/L vs. 530.06 μmol/L; p = 
0.000), BUN at admission (43.20 mmol/L vs. 32.73 
mmol/L; p = 0.006), diuresis (p = 0.032) and 
Potassium (5.44 mmol/L vs. 4.70 mmol/L; p = 0.022). 
Table 4: Comparison of laboratory parameters of elderly 
patients with AKI according to the treatment (hemodialysis / 
conservative) 
Characteristics 
Hemodialysis 
N = 41 
Conservative treatment 
N = 29 
p 
Age (year) 74.00 ± 6.92 74.69 ± 6.29 n.s 
sCr- admission 765.24 ± 288.00 530.06 ± 224.81 0.000 
sCr- discharge 265.09 ± 203.05 207.31 ± 131.75 n.s 
BUN- admission 43.20 ± 17.57 32.73 ± 11.35 0.006 
BUN- discharge 25.54 ± 35.70 18.06 ± 11.28 n.s 
Hb (g/l) 112.89 ± 21.07 104.44 ± 18.85 n.s 
CRP 116.94 ± 114.59 115.57 ± 75.08 n.s 
Na (mmol/l)) 134.92 ± 7.40 137.69 ± 6.65 n.s 
K (mmol/l) 5.44 ± 1.40 4.70 ± 1.16 0.022 
Alb (g/l) 31.42 ± 5.95 33.22 ± 6.20 n.s 
Du (ml) 817.83 ± 819.85 1216.07 ± 574.65 0.032 
Abbreviations: sCr, serum creatinine; BUN, blood urea nitrogen; Hgb, haemoglobin; Plt, 
platelets; Na, sodium; K, Potassium; Alb, albumin; Du, diuresis. 
 
No statistically significant difference was 
evident between the hemodialysis and conservatively 
treated group in term of comorbidities, Diabetes 
mellitus, Chronic Heart Failure and pre-existing 
Chronic Kidney Disease, as shown in Table 5. Figure 
3 presents Kaplan-Meier survival curve between the 
group of patients treated with hemodialysis and group 
of a patient treated conservatively, with no significant 
difference in survival during the follow-up period up to 
90 days (p = 0.633 by the log rank test).  
 
Figure 3: Kaplan-Meier survival curve according to the treatment
   
 
 
Discussion 
  
AKI is a growing disease for the elderly 
patients associated with morbidity and mortality, 
increased requirement for dialysis treatment and 
significantly worse clinical outcome. Our study was 
performed to evaluate the effect of applied treatment 
on short-term outcomes in elderly patients with AKI. 
Seventy patients who met AKI criteria were enrolled in 
the study, with a median age of 74 years and meant 
CCI score of 6.55 ± 2.02 in the group pf survivors and 
even higher (7.9 ± 1.83) in the group of non-survivors 
which indicates high burden of comorbidities. Pre-
existing CKD was present with 44.3%. The most 
common comorbid condition was chronic/acute heart 
failure in 47% of patients. Even in 11% of 
patients "cardiorenal syndrome" (CRS) was the cause 
of AKI which speaks about the bidirectional interaction 
between these two organs. Resent study confirmed 
heart failure as an independent predictor of 
deterioration of renal function [17]. Our results showed 
statistically significant differences regarding heart 
failure between surviving and not a surviving group. 
The second most common comorbidity condition was 
diabetes mellitus which may significantly affect 
kidneys and may potentially increase AKI risk and 
long-term mortality/morbidity of AKI [18] but was not 
confirmed by our study. Significant lower diuresis was 
noted in the group of non-survivors, which could be 
explained by the severity of renal impairment, 
preexisting kidney disease or presence of 
cardiovascular disease that could be associated with 
lower “output”. Also, significant shorter hospitalization 
was registered in no surviving group due to an early 
in- hospital death as a result of an overall critical 
condition of these patients by the worse CCI score, or 
multiple organ failure conditions.  
 Comparing the tree groups of patients divided 
according to the outcomes: group with in-hospital 
mortality group with death occurred during follow up 
period up to 90 days and group of survivors (≥ 90 
days), we found significant differences among 
diuresis, the length of stay, the value of sCr at 
admission and the presence of CHF. Diuresis was 
lowest in the group of patients with in-hospital death, 
which also has registered the highest value sCr 
admission. The sCr was with the lowest value in the 
group of patients in which death occurred during the 
follow-up period; hence the cause of death in this 
group could be explained by the severity of pre-
existing comorbid conditions. The median age 
between surviving and not a surviving group of 
patients also showed no significant statistical 
difference that is in contrary with referenced data from 
EACH study conducted on a large group of the adult 
population [19].     
  The majority of patients were classified at 
AKIN stage 3 (70%) and 20% of patients at AKIN 
stage 2, which points out the severity of AKI in our 
group of patients. Regarding treatment, patients were 
divided into a group with dialysis treatment and group 
with conservative treatment. A high percentage of 
patients (58.6%) underwent hemodialysis, which was 
by severity of AKI. It is expected, significantly higher 
values of BUN and hyperkalemia were noted in the 
hemodialysis treated group. 
 Mortality rate registered in our study was 
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52.8% which is by the results of another study which 
referred mortality rate from 50.7% up to 66% [20, 21]. 
In-hospital mortality was 28.6%, and in 24.3% of 
cases, death occurred during the follow-up period of 
90 days. In our study, the comparative outcome in 
patients with conservative and RRT treatment did not 
show significant differences in survival (log rank p = 
0.633) during the follow-up period which is by reports 
of Van Berendoncks et al. [22-24] that also showed no 
differences in long-term survival according to different 
treatment options. But our study results also deviate 
from the data of the other study which referred poor 
prognosis and increased mortality (after correction for 
disease severity) among elderly patients who 
developed dialysis requiring AKI [21, 25, 26]. 
  Our findings revealed that decreased volume 
of urine was associated with lower survival as its 
shown with Kaplan–Meier survival curves stratified by 
urine volumes at the time of initiation of renal 
replacement therapy (log rank p = 0.001), which is in 
accordance with previous reports where authors 
identified oliguria/anuria as predictor of worse 
outcome [27, 28]. 
 In conclusion, high comorbidity burden is 
common in elderly patients who are at higher risk for 
the development of AKI. In our study survival is not 
related to different treatment options, but decreased 
urine volume is associated with lower survival. Applied 
treatment in elderly patients with AKI should be 
assessed by measuring the long term outcome.  
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